Simplex Trading, LLC Oncocyte Corp Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.25 - $15.6 $7 - $452	29 New	29 $0
Q2 2022 Aug 03, 2022	SELL	$0.86 - $1.53 $1,599 - $2,845	-1,860 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$1.15 - $2.25 $1,682 - $3,291	1,463 Added 368.51%	1,860 $2,000
Q3 2021 Oct 28, 2021	BUY	$3.53 - $5.89 $1,059 - $1,767	300 Added 309.28%	397 $2,000
Q2 2021 Aug 12, 2021	SELL	$3.77 - $6.0 $1,545 - $2,460	-410 Reduced 80.87%	97 $0
Q1 2021 Apr 26, 2021	SELL	$2.39 - $6.5 $42,319 - $115,095	-17,707 Reduced 97.22%	507 $2,000
Q4 2020 Feb 02, 2021	BUY	$1.38 - $2.63 $25,135 - $47,902	18,214 New	18,214 $43,000
Q3 2020 Oct 14, 2020	SELL	$1.2 - $1.89 $248 - $391	-207 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$1.91 - $3.45 $1,995 - $3,605	-1,045 Reduced 83.47%	207 $0
Q1 2020 Apr 29, 2020	SELL	$1.76 - $3.02 $3,194 - $5,481	-1,815 Reduced 59.18%	1,252 $3,000
Q4 2019 Feb 05, 2020	SELL	$1.51 - $2.27 $3,258 - $4,898	-2,158 Reduced 41.3%	3,067 $6,000
Q3 2019 Oct 15, 2019	BUY	$1.59 - $2.51 $7,997 - $12,625	5,030 Added 2579.49%	5,225 $10,000
Q2 2019 Jul 26, 2019	SELL	$2.49 - $5.45 $311 - $681	-125 Reduced 39.06%	195 $0
Q1 2019 Apr 18, 2019	BUY	$1.47 - $5.91 $470 - $1,891	320 New	320 $0

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.